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Background: Telomeres are DNA-protein complexes at the ends of chromosomes and are essential for preserving genome integrity. Preliminary 
data suggest a correlation between telomere attrition, atherosclerosis and adverse cardiovascular (CV) outcomes in stable CAD.
Methods: We measured telomere length (quantitative PCR) in 5,057 patients (pts) w/ ACS from MERLIN-TIMI 36 and PROVE-IT TIMI 22 followed for 
a mean of 1.2 yrs. We evaluated the risk of CV death, MI, or stroke stratified by tertiles of telomere length and adjusted for differences in baseline 
characteristics.
Results: Shorter telomeres were associated w/ older age, lower BMI, NSTEACS vs STEMI, prior MI and prior stroke. Telomere length demonstrated 
a strong graded relationship with the risk of CV death, MI or stroke, with pts w/ shorter telomeres having the highest event rates (Figure Left; 
P<0.0001). This relationship was consistent across age groups (Figure Right). After adjustment, short telomeres remained strongly associated w/ the 
risk of the composite endpoint (T1 HR 2.39, 95% CI 1.95-2.93, P<0.0001; T2 HR 1.47, 1.19-1.82, P=0.0004) as well as the individual components 
of CV death (T1 vs T3 HR 3.27, 1.91-5.59), MI (HR 1.81, 1.36-2.42) and stroke (HR 3.00, 2.22-4.07) (P<0.0001 for each).
Conclusions: Telomere attrition demonstrates a strong, independent association with adverse CV outcomes in patients with ACS. Telomere length 
may provide the basis for a biological clock which integrates the cumulative effects of biological stressors.
 
